Literature DB >> 23205851

Synthesis of cruentaren A.

Bhaskar Reddy Kusuma1, Gary E L Brandt, Brian S J Blagg.   

Abstract

Cruentaren A, an antifungal benzolactone produced by the myxobacterium Byssovorax cruenta, is highly cytotoxic against various human cancer cell lines and a highly selective inhibitor of mitochondrial F-ATPase. A convergent and efficient synthesis of cruentaren A is reported, based upon a diastereoselective alkylation, a series of stereoselective aldol reactions utilizing Myers' pseudoephedrine propionamide, an acyl bromide mediated esterification, and a ring-closing metathesis (RCM) as the key steps. The RCM reaction was applied for the first time toward the total synthesis of cruentaren A, which led to a convergent and efficient synthesis of the natural product.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23205851      PMCID: PMC3528846          DOI: 10.1021/ol302999v

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


  20 in total

1.  Antitumor activity of efrapeptins, alone or in combination with 2-deoxyglucose, in breast cancer in vitro and in vivo.

Authors:  Adonia E Papathanassiu; Nicholas J MacDonald; David R Emlet; Hong A Vu
Journal:  Cell Stress Chaperones       Date:  2010-10-07       Impact factor: 3.667

2.  (S,S)-(+)-pseudoephedrine as chiral auxiliary in asymmetric acetate aldol reactions.

Authors:  Mónica Rodríguez; Jose L Vicario; Dolores Badía; Luisa Carrillo
Journal:  Org Biomol Chem       Date:  2005-04-22       Impact factor: 3.876

3.  Synthesis of the core structure of cruentaren A.

Authors:  Viktor V Vintonyak; Martin E Maier
Journal:  Org Lett       Date:  2007-01-27       Impact factor: 6.005

4.  Concise total synthesis of cruentaren A.

Authors:  Alois Fürstner; Martin Bindl; Ludovic Jean
Journal:  Angew Chem Int Ed Engl       Date:  2007       Impact factor: 15.336

5.  Total synthesis of cruentaren A.

Authors:  Viktor V Vintonyak; Martin E Maier
Journal:  Angew Chem Int Ed Engl       Date:  2007       Impact factor: 15.336

6.  F1F0-ATP synthase functions as a co-chaperone of Hsp90-substrate protein complexes.

Authors:  Adonia E Papathanassiu; Nicholas J MacDonald; Akos Bencsura; Hong A Vu
Journal:  Biochem Biophys Res Commun       Date:  2006-05-02       Impact factor: 3.575

7.  Two-Dimensional NMR Analysis of Acetonide Derivatives in the Stereochemical Assignment of Polyol Chains: The Absolute Configurations of Dermostatins A and B.

Authors:  Scott D. Rychnovsky; Timothy I. Richardson; Bruce N. Rogers
Journal:  J Org Chem       Date:  1997-05-02       Impact factor: 4.354

8.  Hsp90 and mitochondrial proteases Yme1 and Yta10/12 participate in ATP synthase assembly in Saccharomyces cerevisiae.

Authors:  Brian R Francis; Peter E Thorsness
Journal:  Mitochondrion       Date:  2011-03-23       Impact factor: 4.160

9.  Cruentaren A, a highly cytotoxic benzolactone from Myxobacteria is a novel selective inhibitor of mitochondrial F1-ATPases.

Authors:  Brigitte Kunze; Florenz Sasse; Helmut Wieczorek; Markus Huss
Journal:  FEBS Lett       Date:  2007-07-03       Impact factor: 4.124

10.  Synthesis and biological evaluation of cruentaren A analogues.

Authors:  Viktor V Vintonyak; Marcellino Calà; Frank Lay; Brigitte Kunze; Florenz Sasse; Martin E Maier
Journal:  Chemistry       Date:  2008       Impact factor: 5.236

View more
  3 in total

Review 1.  Natural products and other inhibitors of F1FO ATP synthase.

Authors:  Bhargav A Patel; Terin L D'Amico; Brian S J Blagg
Journal:  Eur J Med Chem       Date:  2020-09-03       Impact factor: 6.514

2.  Stereocontrolled synthesis of syn-β-Hydroxy-α-amino acids by direct aldolization of pseudoephenamine glycinamide.

Authors:  Ian B Seiple; Jaron A M Mercer; Robin J Sussman; Ziyang Zhang; Andrew G Myers
Journal:  Angew Chem Int Ed Engl       Date:  2014-04-01       Impact factor: 15.336

3.  Cruentaren A binds F1F0 ATP synthase to modulate the Hsp90 protein folding machinery.

Authors:  Jessica A Hall; Bhaskar Reddy Kusuma; Gary E L Brandt; Brian S J Blagg
Journal:  ACS Chem Biol       Date:  2014-02-12       Impact factor: 5.100

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.